Drugs / RCS-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02391935 | Oct 2015 → Jul 2017 | skin atrophy | RepliCel Life Sciences, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RCS-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02391935 ↗ |
| Modality | Cell therapy | “Cultured, autologous hair follicle cells suspended in cryomedium” NCT02391935 ↗ |